RecruitingNot Applicable

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Brazil, Chile, Colombia5,000 participantsStarted 2019-11-01

Plain-language summary

The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with verified gastric cancer (Group 1 \& 2) * Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5) * Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4) * Motivation to participate in the study * Physical status allowing volatile marker sampling and other procedures within the protocol * Signed consent Exclusion Criteria: * Known other active cancer * Ventilation problems, airway obstruction * Unwillingness or inability to co-operate

What they're measuring

Characteristic VOC pattern identification for gastric cancer detection

Timeframe: 2 years following initiation of patient recruitment

Specific chemistry identification in the exhaled breath

Timeframe: 2 years following initiation of patient recruitment

Trial details

NCT IDNCT04022109

SponsorUniversity of Latvia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12

Contact for this trial

Marcis Leja, MD, PhD

+37129497500 marcis.leja@lu.lv

View on ClinicalTrials.gov More Gastric Cancer trials